Variant report

Variant	esv3471441
Chromosome Location	chr11:85055781-85061154
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 198 )
Associated
traits (count: 80 )

Variant overlapped rSNPs/rCNVs (count:198 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs553183216	chr11:85055792-85055793	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs568241783	chr11:85055795-85055796	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs185024550	chr11:85055845-85055846	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs113429383	chr11:85055917-85055918	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs556951991	chr11:85055923-85055924	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs537446815	chr11:85055942-85055943	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs189825856	chr11:85055955-85055956	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs542661073	chr11:85055965-85055966	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs551253833	chr11:85056006-85056007	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs183859196	chr11:85056037-85056038	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs77143109	chr11:85056049-85056050	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs150808426	chr11:85056067-85056068	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs189218712	chr11:85056083-85056084	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs193107722	chr11:85056113-85056114	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs529022354	chr11:85056142-85056143	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs544196427	chr11:85056160-85056161	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs377363355	chr11:85056163-85056164	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs531189392	chr11:85056194-85056195	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs183471915	chr11:85056201-85056202	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs571165046	chr11:85056210-85056211	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs187585486	chr11:85056229-85056230	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs543535945	chr11:85056277-85056278	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs547192947	chr11:85056310-85056311	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs568180857	chr11:85056333-85056334	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs191657775	chr11:85056377-85056378	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs535561046	chr11:85056388-85056389	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs556890571	chr11:85056433-85056434	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs138377357	chr11:85056436-85056437	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs567907223	chr11:85056500-85056501	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs574708125	chr11:85056508-85056509	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs372706851	chr11:85056586-85056587	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs539861639	chr11:85056589-85056590	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs75463347	chr11:85056612-85056613	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs573121592	chr11:85056617-85056618	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs533721109	chr11:85056623-85056624	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs555616476	chr11:85056661-85056662	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs573737623	chr11:85056744-85056745	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs184285982	chr11:85056770-85056771	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs562622273	chr11:85056791-85056792	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs376221510	chr11:85056830-85056831	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs188189314	chr11:85056864-85056865	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs145054966	chr11:85056874-85056875	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs564594224	chr11:85056914-85056915	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs34442916	chr11:85056969-85056970	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs528795469	chr11:85056987-85056988	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs377685578	chr11:85057010-85057011	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs546747477	chr11:85057024-85057025	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs553180568	chr11:85057039-85057040	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs199602542	chr11:85057074-85057075	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs200778054	chr11:85057077-85057078	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:80)

Disease	PMID	Source
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Wilms tumour	21544195	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Acute myeloid leukemia	20729466	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Multiple myeloma	16461302	CNVD
Glioblastoma multiforme	21080181	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Cervical cancer	21062161	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	17899364	CNVD
Breast cancer	17157792	CNVD
Esophageal squamous carcinoma	18350619	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Neuroblastoma	18923191	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	22429812	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Ovarian neoplasms	16753589	CNVD
Breast cancer	16608533	CNVD
Ovarian cancer	20844748	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
T-cell lymphomas	19863542	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Colorectal cancer	16912164	CNVD
Mental retardation	17847001	CNVD
Melanoma	19509136	CNVD
Sudden cardiac death	19188705	CNVD
Prostate cancer	16573809	CNVD
Basal cell lymphoma	17053054	CNVD
Hepatocellular carcinoma	16785998	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Acute myeloid leukemia	21251322	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21785460	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Cancer	20164920	CNVD
Developmental delay	21147756	CNVD
Bipolar disorder	19114987	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Ductal carcinoma	22052326	CNVD
Obesity	20622171	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD

Chromatin state (count:37 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:85049600-85059400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr11:85053000-85056600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
3	chr11:85055000-85057200	Enhancers	HUES64 Cell Line	embryonic stem cell
4	chr11:85055200-85056400	Weak transcription	HUES48 Cell Line	embryonic stem cell
5	chr11:85055400-85056400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
6	chr11:85056200-85056800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
7	chr11:85056200-85057000	Enhancers	ES-I3 Cell Line	embryonic stem cell
8	chr11:85056200-85060200	Enhancers	H1 Cell Line	embryonic stem cell
9	chr11:85056400-85057000	Enhancers	iPS-15b Cell Line	embryonic stem cell
10	chr11:85056400-85057200	Enhancers	HUES48 Cell Line	embryonic stem cell
11	chr11:85056400-85059000	Enhancers	iPS-18 Cell Line	embryonic stem cell
12	chr11:85056600-85057000	Enhancers	H9 Cell Line	embryonic stem cell
13	chr11:85056600-85060400	Enhancers	iPS-20b Cell Line	embryonic stem cell
14	chr11:85056800-85057800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
15	chr11:85057000-85057400	Weak transcription	ES-I3 Cell Line	embryonic stem cell
16	chr11:85057000-85057400	Weak transcription	H9 Cell Line	embryonic stem cell
17	chr11:85057000-85057400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
18	chr11:85057200-85057600	Weak transcription	HUES48 Cell Line	embryonic stem cell
19	chr11:85057200-85057600	Weak transcription	HUES64 Cell Line	embryonic stem cell
20	chr11:85057400-85058600	Enhancers	H9 Cell Line	embryonic stem cell
21	chr11:85057400-85059000	Enhancers	iPS-15b Cell Line	embryonic stem cell
22	chr11:85057400-85060000	Enhancers	ES-I3 Cell Line	embryonic stem cell
23	chr11:85057600-85060200	Enhancers	HUES64 Cell Line	embryonic stem cell
24	chr11:85057600-85060600	Enhancers	HUES48 Cell Line	embryonic stem cell
25	chr11:85057800-85059000	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
26	chr11:85057800-85060200	Enhancers	HUES6 Cell Line	embryonic stem cell
27	chr11:85057800-85060200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
28	chr11:85058200-85058600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
29	chr11:85059000-85059400	Weak transcription	iPS-15b Cell Line	embryonic stem cell
30	chr11:85059000-85059400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
31	chr11:85059400-85059600	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
32	chr11:85059400-85060000	Enhancers	iPS-18 Cell Line	embryonic stem cell
33	chr11:85059400-85060200	Enhancers	iPS-15b Cell Line	embryonic stem cell
34	chr11:85059600-85060000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
35	chr11:85060000-85070600	Weak transcription	ES-I3 Cell Line	embryonic stem cell
36	chr11:85060200-85079000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
37	chr11:85060400-85061000	ZNF genes & repeats	iPS-20b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links